*Advancing Adaptive Trial Design Methodology

Provide a description of the investment and the desired outcome. This initiative supports the development, standardization, and implementation of advanced adaptive trial design methodology across three priority areas:(1) Bayesian prior specification and sensitivity analysis frameworks, (2) adaptive trial design applications in rare disease and medical device development, and (3) principled single-arm trial design with robust inferential standards.

Estimated value

>= $700K and < $1.5M

Est. solicitation date

Jul 1, 2026

Anticipated award

Jan 1, 2027